Techorizon to Launch Innovative TH-eClinical Suite at DIA Annual Meeting - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Techorizon to Launch Innovative TH-eClinical Suite at DIA Annual Meeting

Source: Company News Release
Techorizon, a leading provider of clinical technology solutions, will launch the TH-eClinical suite of clinical research products at a press event on Tuesday, June 17, at the Drug Information Association Annual Meeting (DIA) in San Diego.

The TH-eClinical suite consists of four integrated research modules, including TH-eCRF (21 CFR Part 11 compliant electronic case report form), TH-eDiary (flexible ePRO patient diary), TH-eSurvey (intuitive electronic questionnaire) and TH-eLearning (a fully validated remote learning application). All applications can be fully integrated or deployed independently and are accessible securely in real time via computer, tablet or smartphone connection with the Cloud.

“TH-eClinical and its individual applications provide a flexible, highly advanced and cost-effective alternative for global research and development,” said Silvio Severini, managing director of Techorizon. “Each TH-eClinical application can be quickly tailored to meet the unique requirements of individual clients and data is validated to GAMP 5 standards and securely archived within our own state-of-the-art infrastructure.”

Part of the CROMSOURCE group of companies, Techorizon combines two decades of clinical development knowledge with a team of health information technology (HIT) experts to help clients improve outcomes and shorten development timelines at a lower cost than competing technologies.

Visitors to CROMSOURCE and Techorizon’s Booth 710 at DIA will see demonstrations of TH-eClinical and be able to register for a chance to win use of a TH-eClinical application in a future project.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Company News Release,
Click here